<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="make word cloud or correlation network from PubMed"><title>wcAbst — wcAbst • wcGeneSummary</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.1.3/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.1.3/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.rawgit.com/afeld/bootstrap-toc/v1.0.1/dist/bootstrap-toc.min.js"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="wcAbst — wcAbst"><meta property="og:description" content="make word cloud or correlation network from PubMed"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">wcGeneSummary</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.99.0</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/basic_usage_of_wcGeneSummary.html">wcGeneSummary</a>
  </div>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"></ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>wcAbst</h1>
      
      <div class="d-none name"><code>wcAbst.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>make word cloud or correlation network from PubMed</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">wcAbst</span><span class="op">(</span></span>
<span>  <span class="va">queries</span>,</span>
<span>  redo <span class="op">=</span> <span class="cn">NA</span>,</span>
<span>  madeUpper <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"dna"</span>, <span class="st">"rna"</span><span class="op">)</span>,</span>
<span>  target <span class="op">=</span> <span class="st">"abstract"</span>,</span>
<span>  usefil <span class="op">=</span> <span class="cn">NA</span>,</span>
<span>  filnum <span class="op">=</span> <span class="fl">0</span>,</span>
<span>  pvclAlpha <span class="op">=</span> <span class="fl">0.95</span>,</span>
<span>  numOnly <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  delim <span class="op">=</span> <span class="st">"OR"</span>,</span>
<span>  geneUpper <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  apiKey <span class="op">=</span> <span class="cn">NULL</span>,</span>
<span>  tfidf <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  pal <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"blue"</span>, <span class="st">"red"</span><span class="op">)</span>,</span>
<span>  numWords <span class="op">=</span> <span class="fl">30</span>,</span>
<span>  scaleRange <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">5</span>, <span class="fl">10</span><span class="op">)</span>,</span>
<span>  showLegend <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  plotType <span class="op">=</span> <span class="st">"wc"</span>,</span>
<span>  colorText <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  corThresh <span class="op">=</span> <span class="fl">0.2</span>,</span>
<span>  layout <span class="op">=</span> <span class="st">"nicely"</span>,</span>
<span>  tag <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  tagWhole <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  onlyCorpus <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  onlyTDM <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  bn <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  R <span class="op">=</span> <span class="fl">20</span>,</span>
<span>  retMax <span class="op">=</span> <span class="fl">10</span>,</span>
<span>  edgeLabel <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  edgeLink <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  ngram <span class="op">=</span> <span class="cn">NA</span>,</span>
<span>  genePlot <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  deleteZeroDeg <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  additionalRemove <span class="op">=</span> <span class="cn">NA</span>,</span>
<span>  orgDb <span class="op">=</span> <span class="va">org.Hs.eg.db</span>,</span>
<span>  preset <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  onWholeDTM <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  madeUpperGenes <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  <span class="va">...</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>
    <dl><dt>queries</dt>
<dd><p>gene symbols (max: 5)</p></dd>


<dt>redo</dt>
<dd><p>if plot in other parameters, input the previous list</p></dd>


<dt>madeUpper</dt>
<dd><p>make the words uppercase in resulting plot</p></dd>


<dt>target</dt>
<dd><p>"abstract" or "title"</p></dd>


<dt>usefil</dt>
<dd><p>filter based on "gstfidf" (whole gene summary tf-idf)
or "bsdbtfidf" (whole bugsigdb tf-idf)</p></dd>


<dt>filnum</dt>
<dd><p>specify filter tfidf</p></dd>


<dt>pvclAlpha</dt>
<dd><p>alpha for pvpick()</p></dd>


<dt>numOnly</dt>
<dd><p>delete number only</p></dd>


<dt>delim</dt>
<dd><p>delimiter for queries</p></dd>


<dt>geneUpper</dt>
<dd><p>make queries uppercase</p></dd>


<dt>apiKey</dt>
<dd><p>api key for eutilities</p></dd>


<dt>tfidf</dt>
<dd><p>use TfIdf when making TDM</p></dd>


<dt>pal</dt>
<dd><p>palette for color gradient in correlation network</p></dd>


<dt>numWords</dt>
<dd><p>the number of words to be shown</p></dd>


<dt>scaleRange</dt>
<dd><p>scale for label and node size in correlation network</p></dd>


<dt>showLegend</dt>
<dd><p>whether to show legend in correlation network</p></dd>


<dt>plotType</dt>
<dd><p>"wc" or "network"</p></dd>


<dt>colorText</dt>
<dd><p>color text label based on frequency in correlation network</p></dd>


<dt>corThresh</dt>
<dd><p>the correlation threshold</p></dd>


<dt>layout</dt>
<dd><p>the layout for correlation network, defaul to "nicely"</p></dd>


<dt>tag</dt>
<dd><p>cluster the words based on text using pvclust</p></dd>


<dt>tagWhole</dt>
<dd><p>tag based on whole data or subset</p></dd>


<dt>onlyCorpus</dt>
<dd><p>return only corpus</p></dd>


<dt>onlyTDM</dt>
<dd><p>return only TDM</p></dd>


<dt>bn</dt>
<dd><p>perform bootstrap-based Bayesian network inference 
instead of correlation using bnlearn</p></dd>


<dt>R</dt>
<dd><p>how many bootstrap when bn is stated</p></dd>


<dt>retMax</dt>
<dd><p>how many items are to be retlieved?</p></dd>


<dt>edgeLabel</dt>
<dd><p>if TRUE, plot the edge label (default: FALSE)</p></dd>


<dt>edgeLink</dt>
<dd><p>if FALSE, use geom_edge_diagonal</p></dd>


<dt>ngram</dt>
<dd><p>default to NA (1)</p></dd>


<dt>genePlot</dt>
<dd><p>plot associated genes (default: FALSE)</p></dd>


<dt>deleteZeroDeg</dt>
<dd><p>delete zero degree node from plot in correlation network</p></dd>


<dt>additionalRemove</dt>
<dd><p>specific words to be excluded</p></dd>


<dt>orgDb</dt>
<dd><p>org database, default to org.Hs.eg.db</p></dd>


<dt>preset</dt>
<dd><p>filter preset words</p></dd>


<dt>onWholeDTM</dt>
<dd><p>calculate correlation network
on whole dataset or top-words specified by numWords</p></dd>


<dt>madeUpperGenes</dt>
<dd><p>make genes upper case automatically (default to TRUE)</p></dd>


<dt>...</dt>
<dd><p>parameters to pass to wordcloud()</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    

<p>list of data frame and ggplot2 object</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="fu">wcAbst</span><span class="op">(</span><span class="st">"DDX41"</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> proceeding without API key</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> proceeding without API key</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $rawdf</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    ID</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1   1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2   2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3   3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4   4</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5   5</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6   6</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7   7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8   8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9   9</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10 10</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    text</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Stimulator of interferon genes (STING) plays important roles in innate immunology. In this study, we isolated the STING gene in Nile tilapia, termed OnSTING. Using quantitative RT-PCR, we explored the expression patterns of the OnSTING gene. Using dual-luciferase reporter assays, we revealed the effect of STING overexpression on nuclear factor κB (NF-κB), IFN and AP activation in HEK 293 cells. Using coimmunoprecipitation, the interaction of STING and TRIF was studied. The effect of OnSTING overexpression on the antibacterial activity in tilapia was investigated. The results showed that upon stimulation with Streptococcus agalactiae, the OnSTING transcript was upregulated in all the tested tissues. OnSTING mRNA levels were very stable from 2.5 to 8.5 dpf. Moreover, OnSTING, OnIFN and IRF3 expression was induced by LPS, Poly (I:C), S. agalactiae WC1535 and DCPS in Nile tilapia macrophages. Overexpression of OnSTING and OnDDX41 increased NF-κB activation in HEK293T cells and slightly increased IFN-β activation but had no effect on AP-1 activation. OnSTING interacted with OnDDX41 and OnTBK1. However, OnSTING did not interact with TRIF. OnSTING overexpression in vivo decreased the sensitivity of tilapia to S. agalactiae infection. These results are helpful for clarifying the innate immune response against bacterial infection in Nile tilapia.Copyright © 2022 Elsevier B.V. All rights reserved.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Deleterious germline DDX41 variants confer risk for myeloid neoplasms (MNs), and less frequently to lymphoid malignancies, with autosomal dominant inheritance and an estimated prevalence of 3% among MNs. Germline DDX41 variants include truncating alleles that comprise about two thirds of all alleles; missense variants located preferentially within the DEAD box domain; and deletion variants. The identification of a truncating allele on tumor-based molecular profiling should prompt germline genetic testing, since virtually all such alleles are germline. Somatic mutation of the wild-type DDX41 allele occurs in about half of MNs with germline DDX41 alleles, typically in exons encoding the helicase domain and most frequently as R525H. Several aspects of deleterious germline DDX41 alleles are noteworthy: (i) Certain variants are common in particular populations; (ii) MNs develop at older ages typical of de novo disease, challenging the paradigm that inherited cancer risk always causes disease in young people; (iii) Despite equal frequencies of these variants in men and women, men progress to MNs more frequently, suggesting a gender-specific effect on myeloid leukemogenesis; and (iv) Individuals with deleterious germline DDX41 variants develop acute severe graft versus host disease after allogeneic hematopoietic cell transplantation with wild-type donors more than others unless they receive post-transplant cyclophosphamide, suggesting a pro-inflammatory milieu that stimulates donor-derived T-cells. Biochemical studies and animal models have identified DDX41's ability to interact with double stranded DNA and RNA:DNA hybrids with roles in mRNA splicing, rRNAs/snoRNAs processing, and modulation of innate immunity, disruption of which could promote inflammation and drive tumorigenesis.Copyright © 2022 American Society of Hematology.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Updating the classification of hematologic neoplasia with germline predisposition, pediatric myelodysplastic syndrome (MDS), and juvenile myelomonocytic leukemia (JMML) is critical for diagnosis, therapy, research, and clinical trials. Advances in next-generation sequencing technology have led to the identification of an expanding group of genes that predispose to the development of hematolymphoid neoplasia when mutated in germline configuration and inherited. This review encompasses recent advances in the classification of myeloid and lymphoblastic neoplasia with germline predisposition summarizing important genetic and phenotypic information, relevant laboratory testing, and pathologic bone marrow features. Genes are organized into three major categories including (1) those that are not associated with constitutional disorder and include CEBPA, DDX41, and TP53; (2) those associated with thrombocytopenia or platelet dysfunction including RUNX1, ANKRD26, and ETV6; and (3) those associated with constitutional disorders affecting multiple organ systems including GATA2, SAMD9, and SAMD9L, inherited genetic mutations associated with classic bone marrow failure syndromes and JMML, and Down syndrome. A provisional category of germline predisposition genes is created to recognize genes with growing evidence that may be formally included in future revised classifications as substantial supporting data emerges. We also detail advances in the classification of pediatric myelodysplastic syndrome (MDS), expanding the definition of refractory cytopenia of childhood (RCC) to include early manifestation of MDS in patients with germline predisposition. Finally, updates in the classification of juvenile myelomonocytic leukemia are presented which genetically define JMML as a myeloproliferative/myelodysplastic disease harboring canonical RAS pathway mutations. Diseases with features overlapping with JMML that do not carry RAS pathway mutations are classified as JMML-like. The review is based on the International Consensus Classification (ICC) of Myeloid and Lymphoid Neoplasms as reported by Arber et al. (Blood 140(11):1200-1228, 2022).© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4  Sex is a major source of diversity among patients and a sex-informed approach is becoming a new paradigm in precision medicine. We aimed to describe sex diversity in myelodysplastic syndromes in terms of disease genotype, phenotype, and clinical outcome. Moreover, we sought to incorporate sex information into the clinical decision-making process as a fundamental component of patient individuality.In this multicentre, observational cohort study, we retrospectively analysed 13 284 patients aged 18 years or older with a diagnosis of myelodysplastic syndrome according to 2016 WHO criteria included in the EuroMDS network (n=2025), International Working Group for Prognosis in MDS (IWG-PM; n=2387), the Spanish Group of Myelodysplastic Syndromes registry (GESMD; n=7687), or the Düsseldorf MDS registry (n=1185). Recruitment periods for these cohorts were between 1990 and 2016. The correlation between sex and genomic features was analysed in the EuroMDS cohort and validated in the IWG-PM cohort. The effect of sex on clinical outcome, with overall survival as the main endpoint, was analysed in the EuroMDS population and validated in the other three cohorts. Finally, novel prognostic models incorporating sex and genomic information were built and validated, and compared to the widely used revised International Prognostic Scoring System (IPSS-R). This study is registered with ClinicalTrials.gov, NCT04889729.The study included 7792 (58·7%) men and 5492 (41·3%) women. 10 906 (82·1%) patients were White, and race was not reported for 2378 (17·9%) patients. Sex biases were observed at the single-gene level with mutations in seven genes enriched in men (ASXL1, SRSF2, and ZRSR2 p&lt;0·0001 in both cohorts; DDX41 not available in the EuroMDS cohort vs p=0·0062 in the IWG-PM cohort; IDH2 p&lt;0·0001 in EuroMDS vs p=0·042 in IWG-PM; TET2 p=0·031 vs p=0·035; U2AF1 p=0·033 vs p&lt;0·0001) and mutations in two genes were enriched in women (DNMT3A p&lt;0·0001 in EuroMDS vs p=0·011 in IWG-PM; TP53 p=0·030 vs p=0·037). Additionally, sex biases were observed in co-mutational pathways of founding genomic lesions (splicing-related genes, predominantly in men, p&lt;0·0001 in both the EuroMDS and IWG-PM cohorts), in DNA methylation (predominantly in men, p=0·046 in EuroMDS vs p&lt;0·0001 in IWG-PM), and TP53 mutational pathways (predominantly in women, p=0·0073 in EuroMDS vs p&lt;0·0001 in IWG-PM). In the retrospective EuroMDS cohort, men had worse median overall survival (81·3 months, 95% CI 70·4-95·0 in men vs 123·5 months, 104·5-127·5 in women; hazard ratio [HR] 1·40, 95% CI 1·26-1·52; p&lt;0·0001). This result was confirmed in the prospective validation cohorts (median overall survival was 54·7 months, 95% CI 52·4-59·1 in men vs 74·4 months, 69·3-81·2 in women; HR 1·30, 95% CI 1·23-1·35; p&lt;0·0001 in the GEMSD MDS registry; 40·0 months, 95% CI 33·4-43·7 in men vs 54·2 months, 38·6-63·8 in women; HR 1·23, 95% CI 1·08-1·36; p&lt;0·0001 in the Dusseldorf MDS registry). We developed new personalised prognostic tools that included sex information (the sex-informed prognostic scoring system and the sex-informed genomic scoring system). Sex maintained independent prognostic power in all prognostic systems; the highest performance was observed in the model that included both sex and genomic information. A five-to-five mapping between the IPSS-R and new score categories resulted in the re-stratification of 871 (43·0%) of 2025 patients from the EuroMDS cohort and 1003 (42·0%) of 2387 patients from the IWG-PM cohort by using the sex-informed prognostic scoring system, and of 1134 (56·0%) patients from the EuroMDS cohort and 1265 (53·0%) patients from the IWG-PM cohort by using the sex-informed genomic scoring system. We created a web portal that enables outcome predictions based on a sex-informed personalised approach.Our results suggest that a sex-informed approach can improve the personalised decision making process in patients with myelodysplastic syndromes and should be considered in the design of clinical trials including low-risk patients.European Union (Horizon 2020 and Transcan programs), Italian Association for Cancer Research, Italian Ministry of Health, and Italian Ministry of University and Research.Copyright © 2022 Elsevier Ltd. All rights reserved.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Germline DDX41 variants have been implicated in late-onset myeloid neoplasms (MNs). Despite an increasing number of publications, many important features of DDX41-mutated MNs remain to be elucidated. Here, enrolling a total of 346 patients with DDX41 pathogenic/likely pathogenic (P/LP) germline variants and/or somatic mutations from 9,082 MN patients, together with 525 first-degree relatives of DDX41-mutated and wild-type (WT) patients, we performed a comprehensive characterization of DDX41-mutated MNs. P/LP DDX41 germline variants explained ~80% of known germline predisposition to MNs in adults. These risk variants were 10-fold more enriched in Japanese MN cases (n=4,461) compared to a Japanese general population (n=20,238). This enrichment of DDX41 risk alleles was much more prominent in male than female (20.7 vs. 5.0). P/LP DDX41 variants conferred a large risk of developing MNs, which was negligible until 40 years old but rapidly increased to 49% by 90 years of age. DDX41-mutated MDS patients rapidly progressed to AML, which was, however, confined to those having truncating variants. Co-mutation patterns at diagnosis and at progression to AML were substantially different between DDX41-mutated and -WT cases, where none of the co-mutations affected clinical outcomes. Even TP53 mutations made no exceptions and their dismal effect, including multi-hit allelic status, on survival was almost completely mitigated by the presence of DDX41 mutations. Finally, outcomes were not affected by the conventional risk stratifications including the revised/molecular International Prognostic Scoring System (IPSS-R/M). Our findings establish that DDX41-mutated MDS defines a unique subtype of MNs that is distinct from other MNs.Copyright © 2022 American Society of Hematology.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   The advent of new technologies has made it possible to identify genetic predispositions to myelodysplastic syndromes (MDS) and acute leukemias (AL) more frequently. The most frequent and best characterized at present are mutations in CEBPA, RUNX1, GATA2, ETV6 and DDX41 and, either in the presence of one of these mutations with a high allelic frequency, or in the case of a personal or family history suggestive of blood abnormalities such as non-immune thrombocytopenia, it is recommended to look for the possibility of a hereditary hematological malignancy (HHM). Indeed, early recognition of these HHMs allows better adaptation of the management of patients and their relatives, as allogeneic hematopoietic stem cell transplantation (HSCT) is very often proposed for these pathologies. According to current data, with the exception of the GATA2 mutation, the constitutional or somatic nature of the mutations does not seem to influence the prognosis of hematological diseases. Therefore, the indication for an allograft will be determined according to the usual criteria. However, when searching for a family donor, it is important to ensure that there is no hereditary disease in the donor. In order to guarantee the possibility of performing the HSC allograft within a short period of time, it may be necessary to initiate a parallel procedure to find an unrelated donor. Given the limited information on the modalities of HSC transplantation in this setting, it is important to assess the benefit/risk of the disease and the procedure to decide on the type of conditioning (myeloablative or reduced intensity). In view of the limited experience with the risk of secondary cancers in the medium and long-term, it may be appropriate to recommend reduced intensity conditioning, as in the case of better characterized syndromic hematological diseases such as Fanconi anemia or telomere diseases. In summary, it seems important to evoke HHM more frequently, particularly in the presence of a family history, certain mutations or persistent blood abnormalities, in order to discuss the specific modalities of HSC allografting, particularly with regard to the search for a donor and the evaluation of certain modalities of the procedure, such as conditioning. It should be noted that the discovery of HHM, especially if the indication of an allogeneic HSC transplant is retained, will raise ethical and psychological considerations not only for the patient, but also for his family. A multidisciplinary approach involving molecular biologists, geneticists, hematologists and psychologists is essential.Copyright © 2022 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  There are considerable new data on mutation topography in persons with myelodysplastic syndromes (MDS). These data have been used to update conventional risk models such as the Revised International Prognostic Scoring System (IPSS-R). Whether the molecular IPSS (IPSS-M) which includes these data improves survival prediction accuracy is untested. To answer this question, we compared survival prediction accuracies of the IPSS-R and IPSS-M in 852 consecutive subjects with de novo MDS. Concordance statistics (C-statistics) of the IPSS-R and IPSS-M in the entire cohort were similar, 0.67 (95% Confidence Interval [CI] 0.64, 0.71) and 0.68 (0.64, 0.71). Average numbers of mutations and of IPSS-M related mutations were greater in persons ≥ 60 years (2.0 [Interquartile Range [IQR], 1, 3] vs. 1.6 [0, 2], P = 0.003; 1.6 [0, 2] vs. 1.3 [0, 2], P = 0.006). Subjects ≥ 60 years had a higher incidence of mutations in RUNX1, TP53, TET2, SRSF2, DNMT3A, STAG2, EZH2 and DDX41. In contrast, mutations in U2AF1 were more common in persons &lt; 60 years. Next we tested survival prediction accuracy based on age &lt; or ≥ 60 years. C-statistics of the IPSS-R and IPSS-M in subjects ≥ 60 years were 0.66 (0.61, 0.71) and 0.69 (0.64, 0.73) whereas in subjects &lt; 60 years they were 0.67 (0.61, 0.72) and 0.65 (0.59, 0.71). These data indicate an advantage for the IPSS-M over the IPSS-R in subjects ≥ 60 years but not in those &lt; 60 years probably because of a great frequency of mutations correlated with survival in those ≥ 60 years.© 2022. The Author(s).</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Fragile X-Syndrome (FXS) represents the most common inherited form of intellectual disability and the leading monogenic cause of Autism Spectrum Disorders. In most cases, this disease results from the absence of expression of the protein FMRP encoded by theFMR1gene (Fragile X messenger ribonucleoprotein 1). FMRP is mainly defined as a cytoplasmic RNA-binding protein regulating the local translation of thousands of target mRNAs. Interestingly, FMRP is also able to shuttle between the nucleus and the cytoplasm. However, to date, its roles in the nucleus of mammalian neurons are just emerging. To broaden our insight into the contribution of nuclear FMRP in mammalian neuronal physiology, we identified here a nuclear interactome of the protein by combining subcellular fractionation of rat forebrains with pull- down affinity purification and mass spectrometry analysis. By this approach, we listed 55 candidate nuclear partners. This interactome includes known nuclear FMRP-binding proteins as Adar or Rbm14 as well as several novel candidates, notably Ddx41, Poldip3, or Hnrnpa3 that we further validated by target-specific approaches. Through our approach, we identified factors involved in different steps of mRNA biogenesis, as transcription, splicing, editing or nuclear export, revealing a potential central regulatory function of FMRP in the biogenesis of its target mRNAs. Therefore, our work considerably enlarges the nuclear proteins interaction network of FMRP in mammalian neurons and lays the basis for exciting future mechanistic studies deepening the roles of nuclear FMRP in neuronal physiology and the etiology of the FXS.Copyright © 2022 Kieffer, Hilal, Gay, Debayle, Pronot, Poupon, Lacagne, Bardoni, Martin and Gwizdek.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Myeloid malignancies with DDX41 mutations are often associated with bone marrow failure and cytopenia before overt disease manifestation. However, the mechanisms underlying these specific conditions remain elusive. Here, we demonstrate that loss of DDX41 function impairs efficient RNA splicing, resulting in DNA replication stress with excess R-loop formation. Mechanistically, DDX41 binds to the 5' splice site (5'SS) of coding RNA and coordinates RNA splicing and transcriptional elongation; loss of DDX41 prevents splicing-coupled transient pausing of RNA polymerase II at 5'SS, causing aberrant R-loop formation and transcription-replication collisions. Although the degree of DNA replication stress acquired in S phase is small, cells undergo mitosis with under-replicated DNA being remained, resulting in micronuclei formation and significant DNA damage, thus leading to impaired cell proliferation and genomic instability. These processes may be responsible for disease phenotypes associated with DDX41 mutations.© 2022. The Author(s).</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Hereditary myeloid malignancies, especially in adults or elderly persons, had been considered quite rare before the next-generation sequencing era; however, increased usage of clinical sequencing has revealed much higher prevalence of inherited myeloid malignancies.DDX41and various pathogenic germline mutations have newly been recognized as the cause of adult-onset familial leukemia and myeloid malignancies. Although germline predisposition to myeloid neoplasms had been categorized as a provisional entity in the World Health Organization classification of hematopoietic neoplasms in 2016, methodology for the identification of hereditary myeloid malignancies has not been fully established yet. In addition, many unresolved problems, such as epidemiology, the exact pathogenic mechanisms, and ideal treatment strategy, including indications of allogeneic hematopoietic stem cell transplantation, still remain. Related donor selection for stem cell transplant is a particularly sensitive issue due to the possibility of germline mutation of the candidate relatives and the risk of donor cell leukemia after transplantation. Here, we reviewed the current evidence regarding epidemiology, diagnosis, mechanisms of progression, and transplantation strategy for hereditary myeloid malignancies.Copyright © 2022 Toya, Harada, Harada and Doki.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>    query</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1  DDX41</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2  DDX41</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3  DDX41</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4  DDX41</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5  DDX41</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6  DDX41</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7  DDX41</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8  DDX41</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9  DDX41</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10 DDX41</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $rawfrequency</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             ddx41                         mutations </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                23                                20 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          germline                              ipss </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                19                                15 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          patients                          variants </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                15                                13 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           euromds                               mds </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                12                                12 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           myeloid                            cohort </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                12                                11 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               mns                               sex </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                11                                11 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           disease                               iwg </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                10                                10 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           onsting                              risk </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                10                                10 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        prognostic                             genes </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 9                                 8 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                   myelodysplastic                           nuclear </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 8                                 8 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          survival                          clinical </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 8                                 7 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              fmrp                           genomic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 7                                 7 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         including                           scoring </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 7                                 7 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       sexinformed                             women </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 7                                 7 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           alleles                          approach </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 6                                 6 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              cell                    classification </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 6                                 6 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              data                      ddx41mutated </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 6                                 6 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               dna                             donor </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 6                                 6 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            months                    predisposition </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 6                                 6 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         syndromes                   transplantation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 6                                 6 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           cohorts                        frequently </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 5                                 5 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        hereditary                          included </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 5                                 5 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         inherited                     international </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 5                                 5 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              jmml                      malignancies </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 5                                 5 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          mutation                         neoplasms </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 5                                 5 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          splicing                          subjects </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 5                                 5 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          syndrome                              tp53 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 5                                 5 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        activation                        allogeneic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             cells                         diagnosis </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          diseases                            family </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          features                           genetic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     hematopoietic                               hsc </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         increased                          leukemia </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    overexpression                        pathogenic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           persons                          registry </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               rna                             roles </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             sting                             study </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           tilapia                         validated </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 4                                 4 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          advances                        agalactiae </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          analysed                             based </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             blood                              bone </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            cancer                            common </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          compared                      conditioning </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    constitutional                         copyright </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       deleterious                          elsevier </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          enriched                        expression </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           finally                         formation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             gata2                     hematological </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               hhm                    identification </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        identified                           include </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            innate                           italian </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         mammalian                            marrow </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        mechanisms                        modalities </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            models                         molecular </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              mrna                         neoplasia </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              nile                          observed </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           outcome                      personalised </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       possibility                        prediction </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          presence                         procedure </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           protein                         relatives </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            remain                           revised </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            rights                             runx1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        sequencing                           somatic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        statistics                              stem </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        truncating                          wildtype </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 3                                 3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     abnormalities                          accuracy </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             acute                            adults </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               age                            allele </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           allelic                         allograft </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          american                               aml </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            author                            biases </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        biogenesis                         candidate </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        categories                             cebpa </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     characterized                        considered </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      conventional                           created </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          criteria                           current </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         cytopenia                          decision </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            degree                           develop </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         disorders                         diversity </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            dnmt3a                            domain </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      epidemiology                              etv6 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          evidence                         expanding </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           failure                           fragile </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         frequency                          function </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            future                              gene </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        generation                            harada </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            health                        hematology </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           history                            immune </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          includes                        indication </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         infection                         intensity </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          interact                       interaction </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       interactome                          japanese </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          juvenile                           leading </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           limited                              loop </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              loss                          lymphoid </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             major                     manifestation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            median                          ministry </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             mrnas                        mutational </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    myelomonocytic                           network </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          neuronal                           neurons </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              novo                           nucleus </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           onddx41                          outcomes </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          paradigm                           pathway </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          pathways                           patient </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          patterns                         pediatric </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        physiology                        population </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        prevalence                           process </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         prognosis                       progression </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        protection                          proteins </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       provisional                           rapidly </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               ras                           reduced </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       replication                          reported </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          revealed                            review </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           society                          specific </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             srsf2                          strategy </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            stress                           studies </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        suggesting                           systems </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            target                            tested </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           testing                              tet2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                  thrombocytopenia                        transplant </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            trials                              trif </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             u2af1                          12001228 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 2                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          aberrant                           ability </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           absence                        accuracies </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          acquired                          activity </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        adaptation                              adar </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          addition                      additionally </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        adultonset                         advantage </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            advent                          affinity </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              aged                              ages </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             aimed                      allografting </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          analysis                            anemia </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            animal                           ankrd26 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            answer                     antibacterial </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               ap1                             apply </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        approaches                             arber </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           aspects                            assays </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            assess                       association </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             asxl1                            autism </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         autosomal                           average </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         bacterial                           bardoni </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             basis                       benefitrisk </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             binds                       biochemical </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        biologists                               box </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           broaden                             built </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           cancers                        candidates </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         canonical                             carry </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       categorized                          category </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           causing                           central </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       challenging                  characterization </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         childhood                        clarifying </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           classic                   classifications </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        classified                    clinicaltrials </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            coding             coimmunoprecipitation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        collisions                         combining </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        completely                         component </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     comprehensive                          comprise </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       concordance                        conditions </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            confer                         conferred </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        confidence                     configuration </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          confined                         confirmed </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       consecutive                         consensus </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      considerable                      considerably </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    considerations                          contrast </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      contribution                       coordinates </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        correlated                       correlation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          critical                  cyclophosphamide </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         cytoplasm                       cytoplasmic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            damage                              dcps </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              dead                           debayle </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            decide                         decreased </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         deepening                            define </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           defined                           defines </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        definition                          deletion </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       demonstrate                            design </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        determined                         developed </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        developing                       development </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        disability                         discovery </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           discuss                            dismal </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          disorder                        disruption </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          distinct                              doki </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          dominant                      donorderived </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            donors                            double </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               dpf                             drive </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    dualluciferase                        dusseldorf </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       dysfunction                       düsseldorf </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           editing                         efficient </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           elderly                        elongation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        elucidated                           elusive </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           emerges                          emerging </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           enables                           encoded </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          encoding                       encompasses </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          endpoint                          enlarges </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        enrichment                         enrolling </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            ensure                            entire </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            entity                             equal </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               era                essentialcopyright </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         establish                       established </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         estimated                           ethical </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          etiology                        evaluation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             evoke                             exact </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         exception                        exceptions </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            excess                          exciting </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             exons                        experience </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         explained                          explored </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            export                              ezh2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            factor                           factors </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          familial                           fanconi </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            female                          findings </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       fmrpbinding                              fold </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        forebrains                           foreign </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              form                          formally </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          founding                     fractionation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        française                       frequencies </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          frequent                       fundamental </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               fxs                      fxscopyright </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               gay                             gemsd </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    genderspecific                       genetically </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       geneticists                          genotype </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             gesmd                        government </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             graft                           growing </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         guarantee                           gwizdek </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         harboring                            hazard </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               hek                           hek293t </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          helicase                           helpful </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       hematologic                     hematologists </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    hematolymphoid                              hhms </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             hilal                           hnrnpa3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           horizon                              host </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              hsct                           hybrids </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               icc                             ideal </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          identify                              idh2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               ifn                             ifnβ </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               iii                          immunity </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        immunology                          impaired </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           impairs                        implicated </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           improve                          improves </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         incidence                       incorporate </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     incorporating                        increasing </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       independent                       indications </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     individuality                       individuals </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           induced                      inflammation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         influence                       inheritance </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          initiate                           insight </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       instability                      intellectual </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        interacted                     interestingly </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        interferon                     interquartile </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          interval                      investigated </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          involved                         involving </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               iqr                              irf3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          isolated                             issue </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           kieffer                        laboratory </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           lacagne                         lateonset </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              lays                               led </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           lesions                         leukemias </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    leukemogenesis                             level </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            levels                            listed </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             local                           located </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               lps                     lymphoblastic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       macrophages                              main </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        maintained                              male </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>             malignanciescopyright              malignanciesddx41and </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        malignancy                        management </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           mapping                            martin </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              mass                            masson </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       mechanistic                   mechanistically </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          medicine                            medium </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         messenger                       methodology </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       methylation                       micronuclei </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            milieu                          missense </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         mitigated                           mitosis </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      mnscopyright                             model </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        modulation                         monogenic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       multicentre                 multidisciplinary </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          multihit                          multiple </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           mutated                       mutations© </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     myeloablative myeloproliferativemyelodysplastic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            nature                       nct04889729 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        negligible                             newly </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           notably                        noteworthy </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     observational                            occurs </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             onifn                            ontbk1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             organ                      organization </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         organized                       overlapping </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             overt                          parallel </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          partners                        pathologic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       pathologies                  patientseuropean </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           pausing                            people </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       performance                         performed </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        performing                            period </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           periods                        persistent </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          personal                             phase </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         phenotype                        phenotypes </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        phenotypic                          platelet </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             plays                           poldip3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              poly                        polymerase </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       populations                            portal </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    posttransplant                         potential </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            poupon                             power </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         precision                       predictions </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        predispose                   predispositions </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    preferentially                          prevents </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         processes                        processing </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         profiling                          programs </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          progress                        progressed </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                   proinflammatory                     proliferation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         prominent                           promote </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            prompt                            pronot </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          proposed                       prospective </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     psychological                     psychologists </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      publications                         published </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              pull                      purification </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      quantitative                          question </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             r525h                              race </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             raise                             range </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              rare                               rat </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             ratio                             rbm14 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               rcc                           receive </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       recognition                         recognize </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        recognized                         recommend </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       recommended                       recruitment </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        refractory                            regard </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        registered                        regulating </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        regulatory                          relevant </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          remained                        replicated </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          reporter                        represents </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          response                       responsible </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            result                          retained </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     retrospective                   retrospectively </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         revealing                          reviewed </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                  revisedmolecular                 ribonucleoprotein </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        rnabinding                            rnadna </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      rrnassnornas                             rtpcr </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             samd9                            samd9l </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                               sas                             score </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            search                         searching </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         secondary                         selection </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         sensitive                       sensitivity </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           setting                            severe </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             short                           shuttle </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        singlegene                         société </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            sought                            source </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           spanish                      spectrometry </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          spectrum                            splice </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                   splicingcoupled                            stable </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             stag2                            status </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             steps                        stimulates </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       stimulation                        stimulator </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          stranded                    stratification </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                   stratifications                     streptococcus </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           studied                       subcellular </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       substantial                           subtype </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        suggestive                       summarizing </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           summary                        supporting </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         syndromic                    targetspecific </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      technologies                        technology </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          telomere                              term </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            termed                             terms </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       thefmr1gene                           therapy </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            thirds                         thousands </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                  tilapiacopyright                              time </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           tissues                             tools </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        topography                             total </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                              toya                          transcan </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        transcript                     transcription </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                   transcriptional          transcriptionreplication </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         transient                       translation </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         treatment                        tumorbased </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>            tumorigenesiscopyright                              type </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           typical                         typically </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                           undergo                        underlying </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             union                            unique </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        university                         unrelated </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        unresolved                          untested </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            update                           updates </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          updating                       upregulated </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             usage                             usual </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                        validation                              view </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                         virtually                              vivo </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            wc1535                             white </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             worse                             zrsr2 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             ·081·                             ·231· </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             ·261·                             ·381· </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             ·443·                             ·459· </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             ·495·                            ·5127· </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                             ·663· </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 1 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $TDM</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> &lt;&lt;TermDocumentMatrix (terms: 771, documents: 10)&gt;&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Non-/sparse entries: 1010/6700</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Sparsity           : 87%</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Maximal term length: 33</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Weighting          : term frequency (tf)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $df</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                            word freq</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> ddx41                     DDX41   23</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> mutations             mutations   20</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> germline               germline   19</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> ipss                       ipss   15</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> patients               patients   15</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> variants               variants   13</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> euromds                 euromds   12</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> mds                         mds   12</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> myeloid                 myeloid   12</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> cohort                   cohort   11</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> mns                         mns   11</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> sex                         sex   11</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> disease                 disease   10</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> iwg                         iwg   10</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> onsting                 onsting   10</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> risk                       risk   10</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> prognostic           prognostic    9</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> genes                     genes    8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> myelodysplastic myelodysplastic    8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> nuclear                 nuclear    8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> survival               survival    8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> clinical               clinical    7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> fmrp                       fmrp    7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> genomic                 genomic    7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> including             including    7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> scoring                 scoring    7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> sexinformed         sexinformed    7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> women                     women    7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> alleles                 alleles    6</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> approach               approach    6</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> $wc</span>
<span class="r-plt img"><img src="wcAbst-1.png" alt="" width="700" height="433"></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Noriaki Sato.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.6.</p>
</div>

    </footer></div>

  

  

  </body></html>

